🇺🇸 FDA
Patent

US 7884226

Purification of rosuvatatin intermediate by thin film evaporation and chemical method

granted A61PA61P3/06A61P9/10

Quick answer

US patent 7884226 (Purification of rosuvatatin intermediate by thin film evaporation and chemical method) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P3/06, A61P9/10